By Mark Campbell and William Collier The COVID-19 pandemic is massively disruptive, and one of the major disruptions is coming from how people communicate and what they expect online. We are seeing anecdotal shifts among our clients and fellow professionals in the digital communications space. But we are also looking at traffic trends […]
By Andy Blom, TES Washington Editor Impeachment. There, we’ve wasted enough time on that. But while we were all trying our best to ignore the dog and pony show in the Senate, free market policy advocates kept working on issues and ideas that affect America, and the world. Read on for this week’s […]
Writing for the Wall Street Journal’s opinion page, Allysia Finley explains that while randomized controlled trials can yield important insights, it is a medical mistake and a disservice to patients to dismiss other types of evidence. Very relevant in the context of COVID-19 treatments, especially hydroxychloroquine. “Some experts have dismissed the antimalarial hydroxychloroquine, or […]
